Gyre Therapeutics (GYRE) Return on Equity (2016 - 2025)
Historic Return on Equity for Gyre Therapeutics (GYRE) over the last 15 years, with Q3 2025 value amounting to 0.08%.
- Gyre Therapeutics' Return on Equity rose 9600.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 9600.0%. This contributed to the annual value of 0.41% for FY2024, which is 34700.0% up from last year.
- According to the latest figures from Q3 2025, Gyre Therapeutics' Return on Equity is 0.08%, which was up 9600.0% from 0.07% recorded in Q2 2025.
- Gyre Therapeutics' 5-year Return on Equity high stood at 14.02% for Q4 2023, and its period low was 2.35% during Q1 2022.
- Moreover, its 5-year median value for Return on Equity was 0.07% (2025), whereas its average is 0.35%.
- Per our database at Business Quant, Gyre Therapeutics' Return on Equity surged by 139500bps in 2023 and then plummeted by -138500bps in 2024.
- Quarter analysis of 5 years shows Gyre Therapeutics' Return on Equity stood at 1.73% in 2021, then skyrocketed by 104bps to 0.07% in 2022, then surged by 20702bps to 14.02% in 2023, then crashed by -99bps to 0.17% in 2024, then tumbled by -53bps to 0.08% in 2025.
- Its Return on Equity was 0.08% in Q3 2025, compared to 0.07% in Q2 2025 and 0.11% in Q1 2025.